Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-02-13, Stock:ABT, The news for the past five days is as follows:
2018-02-06: NEWS1: Centene (CNC) Beats Q4 Earnings & Revenues, Ups '18 View.NEWS2: Centene (CNC) Beats Q4 Earnings & Revenues, Ups '18 View.NEWS3: 3 Top-Rated Dividend Aristocrats For 2018.NEWS4: 3 Top-Rated Dividend Aristocrats For 2018.NEWS5: Reading into Abbott Laboratories’ Valuation.NEWS6: Understanding Abbott Laboratories’ Latest 2018 Guidance.
2018-02-07: NEWS1: Vanguard Value ETF Experiences Big Outflow.NEWS2: Vanguard Value ETF Experiences Big Outflow.NEWS3: 5 Dividend Aristocrats Where Analysts See Capital Gains.NEWS4: 5 Dividend Aristocrats Where Analysts See Capital Gains.NEWS5: Abbott's App for FreeStyle® Libre System Now Available in Europe for Both iPhone™ and Android™.
2018-02-08: NEWS1: With A Recent ROE Of 1.33%, Can Abbott Laboratories (NYSE:ABT) Catch Up To Its Industry?.
2018-02-09: NEWS1: Becton Dickinson’s Fiscal 1Q18 Sales Growth of 5.7% Beat Estimates.NEWS2: See what the IHS Markit Score report has to say about Abbott Laboratories..
2018-02-12: NEWS1: How Bard Acquisition Could Benefit BD.NEWS2: What BD Expects for 2018.NEWS3: How BD Stock Has Performed in the Last Year.NEWS4: Abbott's FreeStyle LibreLink App Now Available in Europe.NEWS5: Abbott's FreeStyle LibreLink App Now Available in Europe.NEWS6: How Did BDX’s LifeSciences Business Perform in Fiscal 1Q18?.NEWS7: Abbott&apos;s FreeStyle LibreLink App Now Available in Europe.NEWS8: BDX’s Fiscal 1Q18 Earnings Results Beat Analysts’ Estimates.

Answer: Rise